Non-invasive assessment of atherosclerotic coronary lesion length using multidetector computed tomography angiography: comparison to quantitative coronary angiography
- 504 Downloads
Multidetector computed tomography angiography (CTA) provides information on plaque extent and stenosis in the coronary wall. More accurate lesion assessment may be feasible with CTA as compared to invasive coronary angiography (ICA). Accordingly, lesion length assessment was compared between ICA and CTA in patients referred for CTA who underwent subsequent percutaneous coronary intervention (PCI). 89 patients clinically referred for CTA were subsequently referred for ICA and PCI. On CTA, lesion length was measured from the proximal to the distal shoulder of the plaque. Quantitative coronary angiography (QCA) was performed to analyze lesion length. Stent length was recorded for each lesion. In total, 119 lesions were retrospectively identified. Mean lesion length on CTA was 21.4 ± 8.4 mm and on QCA 12.6 ± 6.1 mm. Mean stent length deployed was 17.4 ± 5.3 mm. Lesion length on CTA was significantly longer than on QCA (difference 8.8 ± 6.7 mm, P < 0.001). Moreover, lesion length visualized on CTA was also significantly longer than mean stent length (CTA lesion length-stent length was 4.2 ± 8.7 mm, P < 0.001). Lesion length assessed by CTA is longer than that assessed by ICA. Possibly, CTA provides more accurate lesion length assessment than ICA and may facilitate improved guidance of percutaneous treatment of coronary lesions.
KeywordsCoronary artery disease Multidetector computed tomography Quantitative coronary angiography
Invasive coronary angiography (ICA) has been traditionally used for evaluation of the presence and severity of coronary artery disease (CAD). Accordingly, the technique has been extensively utilized to guide further treatment strategies, such as percutaneous coronary intervention (PCI) with stent placement. In particular, the choice for stent length and diameter is frequently decided on the basis of the 2-dimensional ICA images. However, although ICA has an excellent ability to visualize the lumen and severity of luminal narrowing, the presence of atherosclerotic plaque in the arterial wall cannot be accurately visualized . The chosen stent length may not always match the true atherosclerotic plaque length and could potentially lead to insufficient stent coverage of the plaque and possible development of post-stent complications such as arterial dissection, in-stent restenosis and stent thrombosis [2, 3, 4].
Several studies comparing ICA to intravascular ultrasound (IVUS) have shown that ICA indeed underestimates plaque extent [1, 5, 6]. Multidetector computed tomography angiography (CTA) is increasingly used to non-invasively evaluate the presence of CAD [7, 8], and a growing number of patients referred for ICA will have previously undergone non-invasive evaluation by CTA. A particular strength of this modality is that it is able to not only visualize luminal narrowing but also the extent of atherosclerotic plaque in the arterial wall [9, 10]. Accordingly, in patients with previous CTA, who subsequently underwent ICA and PCI, lesion length on CTA was compared to length on ICA.
A total of 89 patients were retrospectively analyzed, who were clinically referred for CTA and had subsequent ICA and PCI with stent implantation. For this retrospective evaluation, consecutive patients were selected as part of an ongoing registry addressing the relative merits of CTA in relation to other imaging techniques . All clinical data were retrieved from the departmental Cardiology Information System (EPD-Vision®, Leiden University Medical Center). In each patient, the presence of CAD risk factors such as diabetes, systemic hypertension, hypercholesterolemia, positive family history, smoking and obesity, were noted.
Multidetector computed tomography coronary angiography
Contra-indications for CTA were (1) (supra) ventricular arrhythmias, (2) renal insufficiency (glomerular filtration rate < 30 ml/min), (3) known allergy to iodine contrast material, (4) severe claustrophobia, (5) pregnancy.
Patients received beta-blocking medication (50–100 mg metoprolol orally, or 5–10 mg intravenously) 1 h before CTA examination if the heart rate was above 65 beats per minute, unless contra-indicated. Forty-seven patients were scanned on a 64-detector row helical scanner (Aquilion 64, Toshiba Medical Systems, Otawara, Japan). Scan parameters were: 400 ms gantry rotation time, 100–135 kV tube voltage and a tube current of 250–350 mA, depending on body shape. Thirty-six patients were scanned on a 320-detector row volumetric scanner (Aquilion ONE, Toshiba Medical Systems, Otawara, Japan). The heart was imaged in a single heartbeat, using prospective triggering with exposure interval depending on the heart rate. Scan parameters were: 350 ms gantry rotation time, 100–135 kV tube voltage and a tube current of 400–580 mA, depending on body mass index. In total, 60–90 ml contrast material (Iomeron 400, Bracco, Milan, Italy) was administered with a rate of 5–6 ml/s followed by a saline flush. Subsequently, data sets were reconstructed in the best available phase and transferred to a remote workstation.
CTA lesion length assessment
Quantitative coronary angiography
Quantitative coronary angiography analysis was performed by observer unaware of CTA findings with the use of QCA-CMS version 6.0 (Medis, Leiden, The Netherlands). Prior to measuring lesion length, images were calibrated with use of the contrast filled catheter. Subsequently, per lesion, the two best orthogonal projections were chosen on which measurements were performed to minimize foreshortening. Consequently, lesion length (mm) was measured from the proximal shoulder to the distal shoulder of the lesion. The longest length measured on QCA was used for further analysis. In addition, highest percent diameter stenosis as measured by QCA was reported for each lesion. The choice and size of stent used were left to the discretion of operator. Per lesion, stent diameter and length were reported. If more than one stent was planned, the total stent length of all combined stents deployed was used.
Continuous variables were expressed as mean and standard deviation, and categorical data were expressed in numbers and percentages. Paired variables were analyzed with Wilcoxon signed rank tests. Statistical analysis was performed using SPSS software (version 16.0, SPSS Inc., Chicago, IL, USA). A P value < 0.05 was considered statistically significant.
Patient characteristics (n = 83)
Age (mean ± SD)
62 ± 10
Obesity (BMI ≥ 30 kg/m2)
Previous stent (%)
Complications during PCI
Comparison between ICA and non-invasive CTA demonstrated that lesion length measured by CTA was substantially longer than lesion length measured by ICA. In addition, lesion length on CTA was compared to the stent length selected for PCI. Interestingly, lesion length measured by CTA significantly exceeded the mean length over which the stent was deployed.
There are only very limited data regarding lesion length measurement with CTA. Soon et al.  compared atherosclerotic lesion length between ICA and CTA (16-slice) in 30 patients and 44 lesions and observed that lesion length was significantly longer on CTA than on ICA with a median difference of 9.8 mm (95% confidence interval of 7.3–13.3). Moreover, the finding that ICA significantly underestimates atherosclerotic lesion length has also been demonstrated by Yamagishi et al, who compared atherosclerotic lesion length on ICA to grayscale IVUS, the current gold standard for the evaluation of atherosclerosis . The authors demonstrated that lesion length on ICA (mean lesion length of 12.4 ± 6.1 mm) was significantly shorter than lesion length measured by IVUS (mean lesion length of 16.3 ± 8.9 mm).
Although angiographically detected coronary atherosclerosis has been linked to outcome in several clinical trials [15, 16, 17, 18], it has been suggested that ICA considerably underestimates the overall extent of CAD . Indeed, when compared to IVUS, the presence of angiographic disease did not reflect true atherosclerotic plaque burden . Mintz et al.  compared the detection of atherosclerosis on ICA to IVUS and found that only 7% of segments described as normal on ICA were truly without any atherosclerotic plaque on IVUS. Conversely, non-invasive CTA has been shown to provide accurate evaluation of coronary plaque burden [9, 20, 21, 22], with a good correlation for detecting and characterizing atherosclerotic plaque in comparison to histology [23, 24, 25]. Moreover, Leber et al.  demonstrated a sensitivity and specificity of 16-slice CTA for the detection of coronary lesions as determined on IVUS of 85 and 92%, respectively. However, small plaques located in distal segments were more difficult to evaluate, particularly in CTA scans with reduced image quality .
The large difference between ICA and CTA lesion length assessment can be explained by the excellent ability of CTA to visualize plaque and vessel remodelling in the arterial wall, in contrast to ICA. Indeed, ICA only shows the contrast filled lumen and is unable to visualize the arterial wall (with the exception of large calcifications), and reference segments may not be optimally evaluated by ICA . Indeed, with traditional invasive coronary angiography, lesions with outward (positive) remodeling are frequently underestimated or missed. Moreover, CTA is not hampered by limitations of angiographic projection such as foreshortening or difficulties in case of tortuous vessels. However, it is of importance to identify the presence of atherosclerosis even at sites without significant luminal narrowing, and some acute coronary syndromes may be triggered by sudden disruption of atherosclerotic plaques that caused neither significant luminal narrowing nor chest pain complaints before the event . It has been suggested that the most rupture prone part of the plaque is not at the maximum point of luminal narrowing but actually located in the shoulders of the plaque . Accordingly, it is important to assess the entire plaque length.
It has also been demonstrated that insufficient coverage of the target lesion increases the risk for in-stent restenosis and stent thrombosis. Fujii et al. retrospectively evaluated lesion characteristics using IVUS leading to stent thrombosis after PCI . The authors observed that stent thrombosis occurred in stents with significantly more residual plaque upstream and downstream from the stent as compared to lesions without stent thrombosis. Okabe et al.  explored which IVUS related findings predicted the risk for the development of stent thrombosis. The authors observed that residual disease at the edge of the stent was associated with subsequent stent thrombosis. Of note, a higher residual plaque burden proximal from the stent has also been associated with increased rates of in-stent restenosis . Accordingly, optimal assessment of the lesion length may improve success and outcome of interventional procedures .
Several limitations need to be addressed. First, there was a time-interval between CTA and PCI during which atherosclerosis may have progressed. Second, only lesions subsequently treated by PCI were included in the study. Therefore, the current observations are only based on lesions with a high grade stenosis. Third, in the current study QCA was not part of the clinical routine of the laboratory and the difference between the CTA lesion length and the stent length chosen reflects the discrepancy between stent length driven by visual assessment. Furthermore, the attending interventional cardiologist did not incorporate lesion topography on CTA before performing PCI. However, future studies should be performed to evaluate the value and improved outcome of CTA lesion assessment prior to PCI.
Lesion length assessed by CTA is longer than lesion length assessed by ICA, which may facilitate improved guidance of percutaneous treatment of coronary lesions.
Dr. van Velzen is supported by the Dutch Heart Foundation (The Hague, The Netherlands), grant no. 2007B223. Dr. de Graaf is co-supported by the Dutch Technology Foundation STW (Utrecht, the Netherlands), applied science division of I and the Technology Program of the Ministry of Economic Affairs, grant no. 10084.
Conflict of interest
Dr. Bax has research grants from BMS medical imaging (New York, USA) and GE Healthcare (Chalfont St Giles, UK).
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
- 9.Achenbach S, Moselewski F, Ropers D et al (2004) Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography: a segment-based comparison with intravascular ultrasound. Circulation 109(1):14–17PubMedCrossRefGoogle Scholar
- 22.Schepis T, Marwan M, Pflederer T et al (2009) Quantification of noncalcified coronary atherosclerotic plaques with dual source computed tomography: comparison to intravascular ultrasound. Heart 96(8):610–615Google Scholar